National and Kapodistrian University of Athens
Νευροενδοκρινής διαφοροποίηση του καρκίνου του προστάτη: Ο ρόλος των γλουταμικών υποδοχέων στα κύτταρα PC-3 (mGluR)
Abstract
dc:descriptionINTRODUTION: Glutamatergic system (Glu System) has been proved to be expressed outside the Central Nervous System (CNS) in cancer cells. Neuroendocrine differentiation in prostate cancer is associated with the aggressive androgen independent prostate cancer. The neuroendocrine cells come of non neuroendocrine cells. They express receptors and secrete factors that act in paracrine way exciting the survival the growth and the metastasis of prostate cancer cells. GOAL: We therefore programmed to characterize the Glu System in the PC-3 (androgen independent) and in the LNCaP cells (androgen dependent). LNCaP cells were also treated with dihydrotestosterone (DHT). Normal epithelial prostate cells (HPREC) were also characterized. Finally, we wanted to check the regulation pattern of the Glu System components under the treatment of certain growth factors, cytokines, hormones and glycocorticoids abundant at the microenvironment of bone. METHODS: The characterization of these two cell lines completed via PCR. In LNCaP 100nM DHT was also added. Moreover western blott analysis was held in this cell lines, in addition to mRNA analysis. The characterization of HPREC upon the category of mGlurs was held in mRNA level by PCR. Finally, the regulation of mGluR1, EAAT1 and the enzyme GS were analyzed at mRNA level, via relative quantitative PCR. Cells were treated for 24H and 48H with the growth factors (bFGF, IGF-1, TGFβ1), cytocines (IL-6), and glycocorticoids (Dexamethazone). RESULTS-CONCLUTIONS: Our research proved that almost the whole of the Glu System is expressed in both PC-3 and LNCaP cells, while it is absent in HPREC cells. Some components of the Glu System seem to be regulated by androgens. Finally, the components of the Glu System don’t seem to be regulated by the factors that are abundant at the microenvironment of bone. The fact that almost the whole of the Glu System is expressed in both PC-3 and LNCaP cells, in contrary with the HPREC cells, leads us to conclude that the expression of the Glu System play crucial role in the evolution of the pathophysiology of prostate cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pissimissis, Nikolaos
- Πισιμίσης, Νικόλαος
Subjects
dc:subject × 20- Καρκίνος προστάτη
- Νευροενδοκρινής διαφοροποίηση
- Γλουταμικό
- Γλουταμινεργικό σύστημα
- PC-3 LNCAP κύτταρα
- Φυσιολογικά προστατικά επιθηλιακά κύτταρα
- Μεταβοτροπικοί υποδοχείς
- Γλουταμική συνθετάση
- Prostate cancer
- Neuroendocrine differentiation
- Glutamate
- Glutamatergic system
- PC-3 LNCAP cells
- Normal epithelial prostate cells (HPREC)
- Metabotropic receptors (MGLUR)
- Glutamate synthetase
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27165